Last reviewed · How we verify
Placebo for recFSH
A placebo control arm used in clinical trials to evaluate the efficacy of recombinant follicle-stimulating hormone (recFSH) in fertility treatment.
A placebo control arm used in clinical trials to evaluate the efficacy of recombinant follicle-stimulating hormone (recFSH) in fertility treatment. Used for Control arm in clinical trials for recombinant FSH in female infertility / assisted reproductive technology.
At a glance
| Generic name | Placebo for recFSH |
|---|---|
| Sponsor | Organon and Co |
| Modality | Small molecule |
| Therapeutic area | Reproductive Medicine / Fertility |
| Phase | Phase 3 |
Mechanism of action
This is an inert control substance administered in phase 3 trials comparing recFSH efficacy against no active treatment. Placebo arms establish baseline outcomes and allow researchers to distinguish genuine pharmacological effects of recFSH from natural disease progression or psychological effects in infertility patients.
Approved indications
- Control arm in clinical trials for recombinant FSH in female infertility / assisted reproductive technology
Common side effects
Key clinical trials
- To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (PHASE3)
- Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)
- Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)
- Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials of Org 36286 (Study 38817)(P06054)(COMPLETED)
- A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787) (PHASE3)
- Frozen-thawed Embryo Transfer (FTET) Cycle Follow-up Protocol (P06031) (PHASE3)
- To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001) (PHASE3)
- Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05690 (Care Program) (P05710)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |